Clinical case analysis of novel coronavirus pneumonia complicated with pulmonary hypertension
Q4 Medicine
Lianshuang Wang, L. Bai, Jing-Jin Yu, Liping Wang, Xuemei Wang, P. Xiang, Xuesong Gao, Yao Zhang
{"title":"Clinical case analysis of novel coronavirus pneumonia complicated with pulmonary hypertension","authors":"Lianshuang Wang, L. Bai, Jing-Jin Yu, Liping Wang, Xuemei Wang, P. Xiang, Xuesong Gao, Yao Zhang","doi":"10.3760/CMA.J.CN114015-20200509-00506","DOIUrl":null,"url":null,"abstract":"Objective: To report the clinical features of pulmonary hypertension diagnosed by echocardiography in 5 patients with novel coronavirus pneumonia (COVID-19) in order to understand the special clinical manifestations of COVID-19 and explore the possible mechanism. Method(s): The echocardiographic data and clinical characteristics of COVID-19 patients complicated with pulmonary hypertension diagnosed by echocardiography in Beijing Ditan Hospital, Capital Medical University were analyzed descriptively from February 5 to March 31, 2020. Result(s): A total of 15 patients with severe and critical COVID-19 patients underwent echocardiography. Of them, 7 patients were diagnosed with pulmonary hypertension, 5 of which were confirmed as complications of COVID-19. Among the 5 patients, 4 were female and 1 was male, aged 62-78 years;4 were with hypertension, 3 were with diabetes, and 1 was with coronary atherosclerotic heart disease. All 5 critically ill patients with COVID-19 were given ventilator-assisted breathing, 2 of which were given extracorporeal membrane oxygenation at the same time. According to echocardiography, the systolic pressure of pulmonary artery in 5 patients was 43-65 mmHg, with an average of 54 mmHg. The severity of pulmonary hypertension was graded as mild in 1 patient and moderate in 4 patients. During the follow-up, pulmonary artery systolic pressure gradually decreased to normal in 4 patients, and then ventilator and ECMO were withdrawn;1 patient died due to respiratory failure and persistent pulmonary hypertension. Conclusion(s): Patients with COVID-19 may be complicated by pulmonary hypertension, which is often found in the critical patients. Echocardiography is an important imagingdiagnostic method for pulmonary hypertension in patients with COVID-19.Copyright © 2020 by the Chinese Medical Association.","PeriodicalId":7863,"journal":{"name":"药物不良反应杂志","volume":"19 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"药物不良反应杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.CN114015-20200509-00506","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To report the clinical features of pulmonary hypertension diagnosed by echocardiography in 5 patients with novel coronavirus pneumonia (COVID-19) in order to understand the special clinical manifestations of COVID-19 and explore the possible mechanism. Method(s): The echocardiographic data and clinical characteristics of COVID-19 patients complicated with pulmonary hypertension diagnosed by echocardiography in Beijing Ditan Hospital, Capital Medical University were analyzed descriptively from February 5 to March 31, 2020. Result(s): A total of 15 patients with severe and critical COVID-19 patients underwent echocardiography. Of them, 7 patients were diagnosed with pulmonary hypertension, 5 of which were confirmed as complications of COVID-19. Among the 5 patients, 4 were female and 1 was male, aged 62-78 years;4 were with hypertension, 3 were with diabetes, and 1 was with coronary atherosclerotic heart disease. All 5 critically ill patients with COVID-19 were given ventilator-assisted breathing, 2 of which were given extracorporeal membrane oxygenation at the same time. According to echocardiography, the systolic pressure of pulmonary artery in 5 patients was 43-65 mmHg, with an average of 54 mmHg. The severity of pulmonary hypertension was graded as mild in 1 patient and moderate in 4 patients. During the follow-up, pulmonary artery systolic pressure gradually decreased to normal in 4 patients, and then ventilator and ECMO were withdrawn;1 patient died due to respiratory failure and persistent pulmonary hypertension. Conclusion(s): Patients with COVID-19 may be complicated by pulmonary hypertension, which is often found in the critical patients. Echocardiography is an important imagingdiagnostic method for pulmonary hypertension in patients with COVID-19.Copyright © 2020 by the Chinese Medical Association.
新型冠状病毒肺炎合并肺动脉高压临床病例分析
目的:报道5例新型冠状病毒肺炎(COVID-19)超声心动图诊断肺动脉高压的临床特点,了解新型冠状病毒肺炎的特殊临床表现,探讨其可能的发病机制。方法:描述性分析2020年2月5日至3月31日首都医科大学附属北京地坛医院超声心动图诊断的新冠肺炎合并肺动脉高压患者的超声心动图资料及临床特征。结果:15例重症、危重型新冠肺炎患者行超声心动图检查。其中7例患者诊断为肺动脉高压,其中5例确诊为新冠肺炎并发症。5例患者中,女性4例,男性1例,年龄62 ~ 78岁;高血压4例,糖尿病3例,冠状动脉粥样硬化性心脏病1例。5例危重患者均给予呼吸机辅助呼吸,其中2例同时给予体外膜氧合。超声心动图显示,5例患者肺动脉收缩压43 ~ 65 mmHg,平均54 mmHg。肺高压严重程度分为轻度1例,中度4例。随访中4例患者肺动脉收缩压逐渐降至正常,随后停用呼吸机及ECMO;1例患者因呼吸衰竭及持续性肺动脉高压死亡。结论:新冠肺炎患者可合并肺动脉高压,常见于危重患者。超声心动图是新冠肺炎患者肺动脉高压的重要影像学诊断手段。中华医学会版权所有©2020。
本文章由计算机程序翻译,如有差异,请以英文原文为准。